Cardiovascular Risk in Women After Metabolic Complications in Pregnancy

Overview

Journal Neth Heart J

Specialty Cardiology & Vascular Diseases

Date 2008 Feb 2

PMID 18239738

Citations 3

Authors

A H E M Maas

A W J van t Hof

M J de Boer

Affiliations

Soon will be listed here.

Abstract

Hypertensive pregnancy disorders complicate 10% of all pregnancies. In this article we discuss the spectrum of hypertensive conditions that may occur during pregnancy. Recent studies have consistently shown that hypertensive disorders in pregnancy implicate a two-fold higher risk for the development of hypertension and cardiovascular disease later in life. To optimise preventive management of cardiovascular disease in women with previous complicated pregnancies, we therefore recommend monitoring of hypertension and other cardiac risk factors at an early stage in life. Furthermore, the obstetric history should be routinely incorporated in cardiovascular risk assessment in women who seek medical attention for hypertension and/or cardiac symptoms. (Neth Heart J 2007;15:415-7.).

Citing Articles

Gestational diabetes mellitus and obstetric outcomes in a Ghanaian community.

Bawah A, Ngala R, Alidu H, Seini M, Wumbee J, Yeboah F Pan Afr Med J. 2019; 32:94.

PMID: 31223385 PMC: 6560956. DOI: 10.11604/pamj.2019.32.94.17334.

[Not Available].

van der Wall E Neth Heart J. 2011; 19(1):1-2.

PMID: 22020853 PMC: 3077836. DOI: 10.1007/s12471-010-0058-0.

Cardiovascular risk in women after metabolic complications in pregnancy.

Maas A, van t Hof A, de Boer M Neth Heart J. 2008; 15(12):415-7.

PMID: 18239738 PMC: 2213446. DOI: 10.1007/BF03086042.

References

Wagner S, Barac S, Garovic V . Hypertensive pregnancy disorders: current concepts. J Clin Hypertens (Greenwich). 2007; 9(7):560-6. PMC: 8109890. DOI: 10.1111/j.1524-6175.2007.06695.x. View

von Dadelszen P, Magee L, Roberts J . Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22(2):143-8. DOI: 10.1081/PRG-120021060. View

Maas A, van t Hof A, de Boer M . Cardiovascular risk in women after metabolic complications in pregnancy. Neth Heart J. 2008; 15(12):415-7. PMC: 2213446. DOI: 10.1007/BF03086042. View

Wilson B, Watson M, Prescott G, Sunderland S, Campbell D, Hannaford P . Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003; 326(7394):845. PMC: 153466. DOI: 10.1136/bmj.326.7394.845. View

Kjos S, Buchanan T . Gestational diabetes mellitus. N Engl J Med. 1999; 341(23):1749-56. DOI: 10.1056/NEJM199912023412307. View

Agatisa P, Ness R, Roberts J, Costantino J, Kuller L, McLaughlin M . Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004; 286(4):H1389-93. DOI: 10.1152/ajpheart.00298.2003. View

Sattar N, Ramsay J, Crawford L, Cheyne H, Greer I . Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension. 2003; 42(1):39-42. DOI: 10.1161/01.HYP.0000074428.11168.EE. View

Sabour S, Franx A, Rutten A, Grobbee D, Prokop M, Bartelink M . High blood pressure in pregnancy and coronary calcification. Hypertension. 2007; 49(4):813-7. DOI: 10.1161/01.HYP.0000258595.09320.eb. View

Raggi P, Shaw L, Berman D, Callister T . Gender-based differences in the prognostic value of coronary calcification. J Womens Health (Larchmt). 2004; 13(3):273-83. DOI: 10.1089/154099904323016437. View

10.

Skjaerven R, Wilcox A, Lie R . The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002; 346(1):33-8. DOI: 10.1056/NEJMoa011379. View

11.

Ray J, Vermeulen M, Schull M, Redelmeier D . Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005; 366(9499):1797-803. DOI: 10.1016/S0140-6736(05)67726-4. View

12.

Innes K, Wimsatt J, McDuffie R . Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol. 2001; 97(6):905-10. DOI: 10.1016/s0029-7844(01)01342-4. View

13.

Kaaja R, Greer I . Manifestations of chronic disease during pregnancy. JAMA. 2005; 294(21):2751-7. DOI: 10.1001/jama.294.21.2751. View

14.

Chambers J, Fusi L, Malik I, Haskard D, de Swiet M, Kooner J . Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001; 285(12):1607-12. DOI: 10.1001/jama.285.12.1607. View

15.

Blaauw J, van Pampus M, van Doormaal J, Fokkema M, Fidler V, Smit A . Increased intima-media thickness after early-onset preeclampsia. Obstet Gynecol. 2006; 107(6):1345-51. DOI: 10.1097/01.AOG.0000218097.22464.b4. View

16.

Savvidou M, Hingorani A, Tsikas D, Frolich J, Vallance P, Nicolaides K . Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003; 361(9368):1511-7. DOI: 10.1016/S0140-6736(03)13177-7. View

17.

Mosca L, Banka C, Benjamin E, Berra K, Bushnell C, Dolor R . Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007; 115(11):1481-501. DOI: 10.1161/CIRCULATIONAHA.107.181546. View

18.

He S, Silveira A, Hamsten A, Blomback M, Bremme K . Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Haemost. 1999; 81(4):538-42. View

19.

Zhang J, Zeisler J, Hatch M, BERKOWITZ G . Epidemiology of pregnancy-induced hypertension. Epidemiol Rev. 1997; 19(2):218-32. DOI: 10.1093/oxfordjournals.epirev.a017954. View

20.

Shah D . The role of RAS in the pathogenesis of preeclampsia. Curr Hypertens Rep. 2006; 8(2):144-52. DOI: 10.1007/s11906-006-0011-1. View